New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 18, 2013
15:06 EDTMNKDMannKind CFO says has 'no news' to account for today's stock movement
MannKind (MNKD) CFO Matthew Pfeffer cites speculation that the company planned to pull out of attending Wells Fargo's conference, which was unfounded. Pfeffer also says some pointed to erroneous reporting of a link between MannKind and Zyprexa, an Eli Lilly (LLY) drug with which MannKind has "no connection," though Pfeffer added that he does not believe confusion about news related to Zyprexa was a cause for the stock move. The comments were made by Pfeffer while speaking at a Wells Fargo healthcare conference.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2015
09:56 EDTMNKDOptions with increasing volume on open
Subscribe for More Information
09:03 EDTMNKDMannKind triples production capacity for Afrezza
MannKind announced that it has completed the validation of two additional filling lines for the manufacture of Afrezza inhalation powder. Material produced during the validation runs, including the recently approved 12 unit cartridges, will be supplied to Sanofi to support the launch of the new dosage strength, which is expected later this quarter.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use